[ORGANIZATION]
Nasdaq Global Market
Featured in 2 tracked stories · first seen
Situations
Braveheart Bio initial public offering
2 clusters · 4 sources · last updated
Latest: Braveheart Bio completes $382M IPO amid insider stock purchases
Braveheart Bio Inc., a biopharmaceutical company focused on therapeutics for hypertrophic cardiomyopathy and other cardiovascular diseases, initiated its initial public offering on the Nasdaq Global Market. The company u
Also covered in
-
Attoria Therapeutics upsized $289 million Nasdaq IPO at $17 per share
[BUSINESS] · 8 sources ·